|Product name||Recombinant SARS-CoV-2 Nucleocapsid Protein with His tag|
|Description||Recombinant SARS-CoV-2(2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2(2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at the N-terminus.|
|Bio-Activity||Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Nucleocapsid at 2μg/mL (100 μL/well) can bind Anti-Nucleocapsid antibody with a linear range of 0.12-1.64 ng/mL.|Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 envelope Protein at 2μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid protein, the EC50 of Recombinant SARS-CoV-2 Nucleocapsid protein is 41.10 ng/mL.|
|Purity||> 95% by SDS-PAGE;> 95% by HPLC.|
|Endotoxin||< 1.0 EU/μg of the protein by LAL method.|
|Formulation||Supplied as a 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH8.0.Contact us for customized product form or formulation.|
|Synonym||Nucleocapsid protein; NP; Nucleoprotein; cov np; Protein N; COVID-19|
|Expressed Host||E. coli|
|Storage||This product is stable at ≤ -70°C for up to 1 year from the date of receipt.|
For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature.
Submit your question about RP01264 below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.
Publishing research using RP01264? Please let us know so that we can cite the reference in this datasheet.
* For research use only. Not for therapeutic or diagnostic purposes.